Results for tag: "Onfi"

Onfi (clobazam) is a central nervous system (CNS) drug used to treat seizures associated with Lennox-Gastaut syndrome (LGS) in children and adults. It is a benzodiazepine, a class of drugs that act on the brain and nerves to produce a calming effect. Onfi works by increasing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that helps regulate nerve activity in the brain. Onfi is available as an oral tablet and an oral solution. Onfi is approved by the U.S. Food and Drug Administration (FDA) for the treatment of seizures associated with LGS in children and adults. It is also approved for use as an adjunctive therapy for seizures associated with other forms of epilepsy in adults and children. The Onfi market is composed of pharmaceutical companies that manufacture and market the drug. Companies in the Onfi market include Lundbeck, Otsuka Pharmaceuticals, Sunovion Pharmaceuticals, and Mylan Pharmaceuticals. Show Less Read more